Reg Joseph
Vice President, Translational, Product & Technology Innovation, Alberta Innovates Health Solutions
Reg has 15 years’ experience in the biotechnology and high technology sectors and has worked with large publically traded firms, start-ups, and the investment banking industry. His prior experience includes serving as an equity research analyst with Boston-based Leerink Swann & Co., where he covered the life science tools sector. He also spent four years at US-based Invitrogen Corp (now Thermo Fisher) in a variety of roles including licensing, product development, acquisitions and integration. Reg has also served in a variety of C-level and board positions with local medical technology-based start-ups.
Reg currently serves on the Board of BioTalent Canada and is a mentor for the AllerGen NCE commercialization program. He also sits on BioAlberta’s policy committee and serves on the board of the Seniors Association of Greater Edmonton (SAGE).
Reg has 15 years’ experience in the biotechnology and high technology sectors and has worked with large publically traded firms, start-ups, and the investment banking industry. His prior experience includes serving as an equity research analyst with Boston-based Leerink Swann & Co., where he covered the life science tools sector. He also spent four years at US-based Invitrogen Corp (now Thermo Fisher) in a variety of roles including licensing, product development, acquisitions and integration. Reg has also served in a variety of C-level and board positions with local medical technology-based start-ups.
Reg currently serves on the Board of BioTalent Canada and is a mentor for the AllerGen NCE commercialization program. He also sits on BioAlberta’s policy committee and serves on the board of the Seniors Association of Greater Edmonton (SAGE).
